J clin oncol. 2009 27 33 : 5594-600
WebApr 1, 2024 · Guigay J, Aupérin A, Fayette J, et al. Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trial. Lancet Oncol 2024; 22: 463–475. WebBackground. Steroid hormones and their receptors play multiple roles in the regulation of biological functions, including sex organ development, pregnancy, bone density, cholesterol mobilization, brain function, cardiovascular system, and more. 1–5 They play an important role in breast cancer development and progression. Almost 70% of breast cancers are …
J clin oncol. 2009 27 33 : 5594-600
Did you know?
WebJ Clin Oncol 2009;27:5594-600. DOI PubMed; 37. Kim SJ, Kim K, Kim BS, et al. Phase II trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK/T-Cell Lymphoma: consortium for Improving Survival of Lymphoma study. J Clin Oncol 2009;27:6027-32. DOI PubMed; 38. WebApr 14, 2024 · INTRODUCTION. Prostate cancer (PCa) results in more than 375,000 deaths worldwide on an annual basis and represents a clinically and biologically diverse disease process. 1-5 A substantial heterogeneity of prognosis exists even within subgroups of PCa defined by clinicopathologic features. 6, 7 As we move beyond clinicopathologic …
WebFeb 2, 2015 · In these reports, the dose and schedule of DCF were as follows: docetaxel (50–70 mg/m 2, Day 1), cisplatin (60–70 mg/m 2, Day 1) and fluorouracil (600–800 mg/m 2, Days 1–5) every 3–4 weeks. Although these reports showed promising efficacy, they also report severe toxicities, particularly those related to myelosuppression. WebApr 12, 2024 · Journal of Clinical Oncology (JCO) is a high-impact, peer-reviewed medical journal that publishes significant clinical oncology research along with editorials, reviews, and other works that relate to the care of patients with cancer. Journal of Clinical Oncology Skip to main content Log In submission complete icon Submit envelope E-Alerts cart Cart
WebNov 3, 2016 · J Clin Oncol 27:5594-5600. © 2009 by American Society of Clinical Oncology INTRODUCTION Extranodal natural killer (NK)/T-cell lymphoma (NKTCL), nasal type,1,2 …
WebJul 29, 2024 · J Clin Oncol 2009;27:5594-600. [ Crossref ] [ PubMed ] Dong LH, Zhang LJ, Wang WJ, et al. Sequential DICE combined with l-asparaginase chemotherapy followed by …
WebJul 1, 2013 · The dosage and administration schedule of CHOP-L were as follows: cyclophosphamide, 750 mg/m 2 intravenously on day 1; vincristine, 1.4 mg/m 2 intravenously on day 1 (maximal dose 2 mg); doxorubicin 50 mg/m 2 intravenously on day 1; dexamethasone 10 mg intravenously on days 1–8; Escherichia coli L-asparaginase … other term for alternative hypothesisWebSep 17, 2024 · J Clin Oncol. 2009;27:5594–600. Article CAS PubMed Central Google Scholar ... J Clin Oncol. 2015;33:2516–22. Article CAS PubMed Central Google Scholar ... rocking castleWebNov 10, 2024 · 33. Arya S, Kim SI, Duwayri Y, et al. Frailty increases the risk of 30-day mortality, morbidity, and failure to rescue after elective abdominal aortic aneurysm repair … rocking ceiling fanWeb2 days ago · Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. © 2024 27 Centers of Multicenter Hematology-Oncology Programs Evaluation System (M-HOPES) First randomized controlled phase III trial of early-stage natural killer/T-cell ... rocking caterpillar toyWebOct 24, 2024 · In 2009, Yamaguchi et al. conducted a trial in localized nasal type using concurrent radiation therapy (50 Gy) and DeVIC chemotherapy (dexamethasone, etoposide, ifosfamide, and carboplatin). The overall response rate was 81%, and 77% of the 27 patients achieved a complete response. other term for alumniWebFeb 28, 2024 · J Clin Oncol. 2009;27 (33):5594–600 (3iiiA). 3. Yamaguchi M, et al. Concurrent chemoradiotherapy for localized nasal natural killer (NK)/T-cell lymphoma: an … rocking cellosWebSep 20, 2010 · Purpose: Salvage chemotherapy followed by high-dose therapy and autologous stem-cell transplantation (ASCT) is the standard treatment for relapsed diffuse large B-cell lymphoma (DLBCL). Salvage regimens have never been compared; their efficacy in the rituximab era is unknown. Patients and methods: Patients with CD20(+) DLBCL in … other term for amonton\u0027s law